For: | Hendifar A, Akinsola R, Muranaka H, Osipov A, Thomassian S, Moshayedi N, Yang J, Jacobs J, Devkota S, Bhowmick N, Gong J. Gut microbiome and pancreatic cancer cachexia: An evolving relationship. World J Gastrointest Oncol 2022; 14(7): 1218-1226 [PMID: 36051103 DOI: 10.4251/wjgo.v14.i7.1218] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v14/i7/1218.htm |
Number | Citing Articles |
1 |
Ruoxin Fang, Ling Yan, Zhengkai Liao. Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1123567
|
2 |
Rima Nasrah, Mary Kanbalian, Christina Van Der Borch, Ken Dewar, Stéphanie Chevalier, R. Thomas Jagoe. Stool Microbiome Features and Weight Change Response to Treatment for cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle 2025; 16(3) doi: 10.1002/jcsm.13816
|
3 |
Hülya Yılmaz Temel, Öznur Kaymak, Seren Kaplan, Basak Bahcivanci, Georgios V. Gkoutos, Animesh Acharjee. Role of microbiota and microbiota‐derived short‐chain fatty acids in PDAC. Cancer Medicine 2023; 12(5): 5661 doi: 10.1002/cam4.5323
|
4 |
Ricardo A León-Letelier, Rongzhang Dou, Jody Vykoukal, Michele T Yip-Schneider, Anirban Maitra, Ehsan Irajizad, Ranran Wu, Jennifer B Dennison, Kim-An Do, Jianjun Zhang, C Max Schmidt, Samir Hanash, Johannes F Fahrmann. Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. Clinical Chemistry 2024; 70(1): 102 doi: 10.1093/clinchem/hvad186
|